Put Options

21 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.96 - $27.6 $1.81 Million - $2.27 Million
-82,200 Reduced 34.02%
159,400 $4.14 Million
Q2 2024

Aug 14, 2024

BUY
$20.34 - $23.73 $4.2 Million - $4.9 Million
206,600 Added 590.29%
241,600 $5.43 Million
Q1 2024

May 15, 2024

SELL
$20.17 - $23.93 $1.79 Million - $2.12 Million
-88,500 Reduced 71.66%
35,000 $830,000
Q4 2023

Feb 14, 2024

SELL
$19.25 - $24.13 $1.67 Million - $2.1 Million
-86,900 Reduced 41.3%
123,500 $2.96 Million
Q3 2023

Nov 14, 2023

BUY
$19.04 - $22.74 $3.43 Million - $4.1 Million
180,400 Added 601.33%
210,400 $4.6 Million
Q2 2023

Aug 14, 2023

SELL
$18.17 - $20.48 $1.54 Million - $1.74 Million
-85,000 Reduced 73.91%
30,000 $573,000
Q1 2023

May 15, 2023

BUY
$16.3 - $19.41 $700,900 - $834,630
43,000 Added 59.72%
115,000 $2.23 Million
Q4 2022

Feb 14, 2023

SELL
$14.96 - $17.39 $493,680 - $573,870
-33,000 Reduced 31.43%
72,000 $1.15 Million
Q3 2022

Nov 14, 2022

BUY
$15.68 - $22.27 $705,600 - $1 Million
45,000 Added 75.0%
105,000 $1.65 Million
Q2 2022

Aug 15, 2022

SELL
$17.44 - $23.16 $87,200 - $115,800
-5,000 Reduced 7.69%
60,000 $1.25 Million
Q4 2021

Feb 11, 2022

SELL
$15.84 - $21.88 $763,488 - $1.05 Million
-48,200 Reduced 42.58%
65,000 $1.19 Million
Q3 2021

Nov 12, 2021

BUY
$16.3 - $21.14 $867,160 - $1.12 Million
53,200 Added 88.67%
113,200 $2.39 Million
Q2 2021

Aug 16, 2021

BUY
$17.95 - $25.56 $1.08 Million - $1.53 Million
60,000 New
60,000 $1.09 Million
Q1 2021

May 17, 2021

SELL
$20.53 - $25.22 $1.23 Million - $1.51 Million
-60,000 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$18.39 - $24.8 $4.49 Million - $6.05 Million
-244,100 Reduced 80.27%
60,000 $1.2 Million
Q3 2020

Nov 16, 2020

BUY
$20.67 - $26.94 $6.29 Million - $8.19 Million
304,100 New
304,100 $7.44 Million
Q2 2020

Aug 14, 2020

SELL
$16.46 - $27.42 $329,200 - $548,400
-20,000 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$14.46 - $21.8 $2.6 Million - $3.92 Million
-180,000 Reduced 90.0%
20,000 $344,000
Q2 2019

Aug 13, 2019

BUY
$18.93 - $24.75 $2.84 Million - $3.71 Million
150,000 Added 300.0%
200,000 $4.27 Million
Q1 2019

May 14, 2019

SELL
$19.6 - $24.76 $4.9 Million - $6.19 Million
-250,000 Reduced 83.33%
50,000 $1.19 Million
Q4 2018

Jan 30, 2019

BUY
$13.65 - $21.8 $4.1 Million - $6.54 Million
300,000 New
300,000 $5.9 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.2B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.